Submit a comment

Decreased Glucagon Receptors in Diabetic Rat Hepatocytes: EVIDENCE FOR REGULATION OF GLUCAGON RECEPTORS BY HYPERGLUCAGONEMIA
Sam J. Bhathena, … , Stewart Smith, Lillian Recant
Sam J. Bhathena, … , Stewart Smith, Lillian Recant
Published June 1, 1978
Citation Information: J Clin Invest. 1978;61(6):1488-1497. https://doi.org/10.1172/JCI109069.
View: Text | PDF

Decreased Glucagon Receptors in Diabetic Rat Hepatocytes: EVIDENCE FOR REGULATION OF GLUCAGON RECEPTORS BY HYPERGLUCAGONEMIA

Abstract

The effects of endogenous and exogenous hyperglucagonemia on the specific binding of glucagon to hepatocyte receptors was studied, as was the response of cAMP to glucagon. In streptozotocin diabetic rats, blood glucose and plasma glucagon increased and plasma insulin decreased as compared with controls. Insulin treatment in diabetic rats restored blood glucose and plasma glucagon toward normal and elevated plasma insulin. Specific binding of 125I-glucagon to isolated hepatocytes (106 cells) decreased in diabetic rats (8.17±0.38%) compared to controls (14.05±0.87%) and was restored by insulin treatment (12.25±0.93%). Specific binding of 125I-insulin in controls was 7.30±10.16%; it increased in diabetic rats to 12.50±0.86%, and decreased in diabetic rats after insulin treatment (9.08±0.87%). Scatchard analysis and the competition plots of the data indicate that decreased glucagon binding and increased insulin binding in diabetes were due to change in the number of receptors rather than a change in their affinity. Hepatocyte cAMP response to glucagon (0.25-5.0 ng/ml) was almost abolished in diabetic rats and was restored with insulin treatment.

Authors

Sam J. Bhathena, Nancy R. Voyles, Stewart Smith, Lillian Recant

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required